Editorial comments on: “Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I”

Genuneit, Jon; Eigenmann, Philippe

doi:10.1111/pai.13729

Cited by 3 publications

(6 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Globally, and in line with our results, the prevalence of AR does not seem to increase any more even if the results vary substantially both between and within countries. 3 Taken together, our results are in line with the recent large multicenter studies showing diverging trends of asthma and AR. 2 , 3 …”

Section: Discussionsupporting

confidence: 91%

“… 3 Taken together, our results are in line with the recent large multicenter studies showing diverging trends of asthma and AR. 2 , 3 …”

Section: Discussionsupporting

confidence: 91%

“… 2 A similar development has been reported for allergic rhinitis (AR). 3 Allergic sensitization is a key step in the development of allergic diseases, and sensitization to airborne allergens is consistently the strongest identified risk factor for asthma and AR. 4 , 5 , 6 Even so, few large-scale studies about trends in allergic sensitization have been published, and there are fewer that have a high-enough participation in a studied community to truly capture a population prevalence.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Prevalence and risk factors for allergic sensitization: 3 cross-sectional studies among schoolchildren from 1996 to 2017

Rönmark¹,

Bunne²,

Bjerg³

et al. 2023

Journal of Allergy and Clinical Immunology: Global

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 91%

“… 3 Taken together, our results are in line with the recent large multicenter studies showing diverging trends of asthma and AR. 2 , 3 …”

Section: Discussionsupporting

confidence: 91%

mentioning

confidence: 99%

See 1 more Smart Citation

Prevalence and risk factors for allergic sensitization: 3 cross-sectional studies among schoolchildren from 1996 to 2017

Rönmark¹,

Bunne²,

Bjerg³

et al. 2023

Journal of Allergy and Clinical Immunology: Global

View full text Add to dashboard Cite

“…Previous studies have variably reported increasing and decreasing trends in AD prevalence among adults, suggesting inconclusive evidence indicating the need for further study [6‒8, 28]. Moreover, these studies had methodological limitations, including limited sample sizes, shorter durations of follow-up, and predominantly focused on children [6, 9, 10, 28]. However, the present findings should also be interpreted in light of limitations.…”

Section: Discussionmentioning

confidence: 67%

“…The strength of this study lies in the large-scale, long-term serial cross-sectional study of 83,566 Korean adults. Previous studies have variably reported increasing and decreasing trends in AD prevalence among adults, suggesting inconclusive evidence indicating the need for further study [6‒8, 28]. Moreover, these studies had methodological limitations, including limited sample sizes, shorter durations of follow-up, and predominantly focused on children [6, 9, 10, 28].…”

Section: Discussionmentioning

confidence: 99%

National Trends and Prevalence of Atopic Dermatitis and Pandemic-Related Factors among Korean Adults, 2007–2021

Kang,

Park,

Lee

et al. 2024

Int Arch Allergy Immunol

View full text Add to dashboard Cite

Introduction: Previous studies have variably reported inconclusive trends in the prevalence of atopic dermatitis (AD) among adults, and there are limited data on the impact of the COVID-19 pandemic. We aimed to investigate the national trends and age-stratified prevalence of AD among adults from 2007 to 2021 in South Korea, focusing mainly on the impact of the COVID-19 pandemic-related factors. Methods: A nationwide cross-sectional study was conducted using the Korea National Health and Nutrition Examination Survey data from 2007 to 2021. Overall and age-stratified prevalence for AD were assessed using weighted beta coefficients or odds ratios. Results: A total of 83,566 adults over 20 years (male, 49.40%) were included. During the observation period, the prevalence of AD was stable in the overall population from 2.61% (95% CI, 2.29–2.93) in 2007–2009 to 2.15% (1.68–2.63) in 2020 and 2.38% (1.81–2.95) in 2021. However, the weighted prevalence of AD in adults aged 40–59 years old decreased during the pre-pandemic era, and the prevalence of AD in adults aged above 60 years significantly decreased during the pandemic, with a significant decline observed after the initial outbreak. From age-stratification analysis, the adults aged 40–59 years showed a significant increase after the pandemic outbreak which was evident in specific variables: individuals with rural residence, lower education, and lower household income quartiles. Adults aged above 60 years showed a significant decrease in the slope after the outbreak, evident in specific variables: individuals of female, rural residence, lower education, and lower household income quartiles. Conclusion: We observed a stable overall prevalence of AD throughout the 15-year observation period. However, the age-stratified analysis suggested significantly different trends according to age-stratified groups and the impact of the COVID-19 pandemic on the prevalence of AD.

show abstract

Global Asthma Network Phase I, India: Results for allergic rhinitis and eczema in 127,309 children and adults

Barne¹,

Singh

Mangal

et al. 2022

Journal of Allergy and Clinical Immunology: Global

View full text Add to dashboard Cite

Editorial comments on: “Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I”

Cited by 3 publications

References 5 publications

Prevalence and risk factors for allergic sensitization: 3 cross-sectional studies among schoolchildren from 1996 to 2017

Prevalence and risk factors for allergic sensitization: 3 cross-sectional studies among schoolchildren from 1996 to 2017

National Trends and Prevalence of Atopic Dermatitis and Pandemic-Related Factors among Korean Adults, 2007–2021

Global Asthma Network Phase I, India: Results for allergic rhinitis and eczema in 127,309 children and adults

Contact Info

Product

Resources

About